Original article on Kentucky New Era
BRENTWOOD, Tenn.–(BUSINESS WIRE)–Oct 4, 2018–Spero Health, a CARF-accredited organization and leader in outpatient addiction treatment, has announced the expansion of its integrated care recovery and medical services with the launch of the company’s 21 st clinic. The Madisonville Spero Health Center, located at 436 N. Main St., opened October 1 to start seeing new patients.
Spero Health’s mission is to “ Save Lives, Instill Hope and Restore Relationships.” Its integrated approach uniquely combines both physical and behavioral healthcare services under one roof to treat the whole patient. This approach incorporates physician office visits, behavioral health counseling, recovery support services and patient and family education. Spero Health provides local and affordable care for more than 5,300 fellow human beings throughout Kentucky, Indiana and Ohio. The expansion into Madisonville is focused on the continued goal to help communities hit hard by the opioid epidemic.
“Every day more than 115 Americans die after overdosing on opioids. Madisonville, like other communities, has seen a dramatic increase in opioid misuse and overdose deaths over the last seven years,” said Steve Priest, CEO. “Our team is not only focused on saving lives, but also on helping strengthen communities impacted by addiction. It is our desire to be an active member of the local healthcare community and a partner in the fight against this deadly disease.”
According to the National Institute on Drug Abuse, Kentucky is among the top 10 states with the highest opioid-related deaths. With 23 deaths per 100,000 people, the overdose rate in Kentucky is double the national average.
“There is no one-size-fits-all approach to addiction treatment, which is why Spero Health tailors every treatment plan to match the unique needs of each individual,” said David Hayden, LCADC, VP of Clinical Services. “Our approach is evidenced-based and designed to allow individuals to remain in their communities throughout treatment so they can continue working and caring for their families, which ultimately enhances their quality of life.”
Spero Health participates with Kentucky Medicaid and is currently accepting new patients from select commercial insurance plans. “We look forward to bringing addiction treatment solutions to Madisonville to help ease the worsening of this epidemic, and our team is working hard to ensure that access to care is not an issue,” said Priest. For more information or to schedule an appointment, please call 1-877-78-SPERO.
The Madisonville location currently has several job openings. Spero Health is seeking qualified counselors, social workers and physicians for the new location. Applicants can view a list of job openings at https://sperohealth.com/careers/.
About Spero Health
Spero Health, Inc., is an integrated healthcare services organization specializing in local and affordable outpatient care for individuals suffering from substance use disorder with a mission to “Save Lives, Instill Hope, and Restore Relationships.” Spero Health utilizes an innovative evidenced-based integrated care model that combines both physical and behavioral healthcare services under one roof to treat the whole patient. This integrated care model combines physician services (including medication assisted treatment), behavioral health counseling, recovery support services, medication management and patient and family education. Its community-based approach to treatment allows patients to continue working and caring for their families as they overcome addiction.
Based in Nashville, Tenn. and privately held by Heritage Group, Health Velocity Capital, South Central, Inc. and Frist Cressey Ventures, Spero Health operates 21 freestanding outpatient clinics located throughout Kentucky, Ohio and Indiana. Providing care for more than 5,300 patients each month, Spero is one of the largest office-based opioid treatment providers in the country and is in network with Medicaid and most commercial insurance plans.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181004005500/en/
CONTACT: Spero Health
Ginger Jackson, 859-209-2296
ginger.jackson@sperohealth.com